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It has been known in the community studying the pathogenesis
of Streptococcus pyogenes that spontaneous mutation occurs
during passages in laboratory media or in animals, so some of the
progeny’s virulence can be changed, mainly due to the change
of the expression of virulence factors.1-3 This phenomenon is not
only limited to S. pyogenes, but also happens to other pathogens.4-6
Like other pathogens, S. pyogenes, a strict human pathogen,
produces virulence factors to attach to and invade host tissues,
avoid the immune system, or degrade or kill host tissues and
cells. These virulence factors are necessary to colonize, invade,
and spread in the host. However, some of these factors are not
necessary to grow in laboratory media, so reduced expression of
these virulence factors could increase the fitness for growth in
laboratory media. A notorious S. pyogenes virulence factor whose
expression changes during passages in the laboratory is M protein.
M protein is a cell wall-anchored protein with a coiled-coil
structure and its important role in S. pyogenes pathogenesis has
long been recognized as an adhesin and antiphagocytic factor.7
It is also the causative molecule of the streptococcal rheumatic
heart disease. The antibodies generated against M protein cross
react with tissues in the heart valves.8 Thus, when S. pyogenes
loses M protein, its virulence is dramatically attenuated in animal
infection models.
It has been a puzzle in the study of S. pyogenes whether
or not the sagA/pel locus influences the expression of the
M protein gene (emm). Several studies on the sagA/pel locus
produced conflicting results on the regulation of M protein
gene expression. However, the recent study by Zhou et al.
in this issue of Virulence shows that the sagA/pel locus does
not regulate the expression of M protein at least in the M1
strains that most studies for the sagA/pel locus used, and the
confusion has been caused by secondary spurious mutations
during mutagenesis.9 This study by Zhou et al. reminds us
of the importance of awareness of spontaneous mutation or
phase variation possibilities during mutagenesis of S. pyogenes.
During laboratory passages, the expression of other virulence

factors such as capsule and the protease SpeB changes,3 so this
phenomenon seems not to be limited to M protein.
Recent genomic studies show that genetic changes in
S. pyogenes occur not only during passages in the laboratory (in
vitro passage) but also during infection (in vivo passage).10-13
Interestingly, these genetic changes are selected mostly in the
virulence factor-regulator genes of mga, covRS, and ropB. In the
study by Zhou et al., the expression of both genes of M protein
and its regulator Mga decreased in strains producing low levels
of M protein after lab passages, and there was no mutation in the
emm and mga promoter region. However, since the expression
of mga is autoregulated,14 it cannot be ruled out that Mga was
mutated in the study. The major virulence factors regulated by
Mga, CovRS, and RopB are M protein, capsule, and SpeB, which
are the same virulence factors whose expression was changed after
laboratory passages. Therefore, the selected mutations during in
vitro passages might also be concentrated in these regulators.
To prevent improper interpretation of a function attributed to
a gene due to spurious secondary mutations, mutagenesis should
be carefully performed and the phenotype of mutants should
be carefully examined. S. pyogenes starts to die quickly after
reaching the stationary phase in THY medium (most popular lab
medium for S. pyogenes) probably due to the lack of nutrients, low
pH (~pH 5.5) etc. It has been known that cells go through more
mutation during conditions not favorable for growth such as in
the stationary phase.15,16 Thus, during mutagenesis, cells should
not stay in the stationary phase too long. After mutagenesis, the
phenotype of several mutant colonies, not just one or two, should
be examined. The expression of the virulence factors M protein,
capsule, and SpeB can be easily examined phenotypically. The
production level of capsule is easily determined by the appearance
and size of colonies on agar plates. The expression level of the
major secreted protease SpeB can be examined by plating cells
on skim milk agar plates.17 Most, if not all, S. pyogenes strains
form aggregates during stationary phase in liquid media, and
M protein is involved in the aggregate formation through
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homophilic protein–protein interactions.18 However, other cell
surface proteins such as M-like proteins, Protein H, and Protein
F are also responsible for the aggregation. Thus, it is wise not to
pick non-aggregated colonies if other colonies are aggregated in
liquid media. However, when the expression of M protein needs
to be tested, a direct method such as western blotting should be
performed.
Another way to confirm the function of a gene attributed
after mutagenesis is to perform the complementation test. Most
commonly, multicopy plasmids are used to complement a gene or
genes in S. pyogenes. Complementation with a multicopy plasmid
is easy to perform, and if it works, the gene can be manipulated
easily by deleting a motif or changing key amino acids through
inverse PCR. However, complementation with a multicopy
plasmid does not work in some cases, perhaps due to the issues
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